LidoSite FDA Approval History
FDA Approved: Yes (First approved May 10, 2004)
Brand name: LidoSite
Generic name: lidocaine and Epinephrine
Dosage form: Topical System
Company: Vyteris, Inc.
Treatment for: Local Anesthesia
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
LidoSite (lidocaine and epinephrine) is an iontophoretic delivery system providing local analgesia prior to the administration of superficial dermatological procedures.
Development timeline for LidoSite
| Date | Article |
|---|---|
| May 10, 2004 | Approval LidoSite Vyteris, Inc. - Treatment for Localized Pain |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.